13th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 1998

January 24-31, 1998
Marilleva, Trento, Italy

RT-137

External electrical cardioversion: the first choice procedure not only in chronic atrial fibrillation

G. Molon, G. Canali, P. Girardi, F. Castagna, G.L. Ferri, F. Stefanini*, G.C. Salazzari.
Department of Cardiology, *Department of Emergency, "S. Cuore" Hospital, Negrar, Italy

Abstract

Is nowadays well know the importance of terminating atrial fibrillation as soon as possible. Farmacologic attempts of cardioversion are often ineffective or with low prediction of success in recent onset and, most important, even less effective and predictable in chronic atrial fibrillation. We retrospectively evaluated effectiveness and safety of external electrical cardioversion in atrial fibrillation.

Methods. From January 1993 to June 1997 154 patients underwent 221 cardioversions for atrial fibrillation. 121 patients with onset > 48 hours or moderate/severe risk of stroke, were anticoagulated with Warfarin to obtain a prothrombin time (INR) range between 2 and 3 for 3 weeks before cardioversion; which was not taken before 1 month from atrial fibrillation onset. A subgroup of 33 patients with onset < 48 hours and low risk of stroke, were not anticoagulated; cardioversion was performed before 48 hours from atrial fibrillation onset. All patients received brief general anesthesia; the paddles were in anterior-posterior position. The initial shock was 200 Joules.

Results. Globally effective cardioversions were 196/221 (89%) - 32/33 (97%) in the subgroup with onset < 48h and 164/188 (87%) in patients with chronic atrial fibrillation; the first shock was effective in 157/196 (80%) successful CV. Adverse events were: asysthole > 3 seconds in 4 patients (2%), junctional rhythm or other bradyarrhytmias in 9 patients (4%). There were no stroke, periferic embolism or adverse events from anesthesia.

Conclusions. Electrical cardioversion in atrial fibrillation is highly efficient in synus rhythm restoration, is also safe, easy to perform and without major adverse events; in our experience 200 Joules seems to be the optimal starting energy; risk stratification of stroke may avoid long-term anticoagulation and electrical remodeling of atria in a subpopulation of patients with recent onset of atrial fibrillation; in these patients electrical cardioversion has very high percentage of success.

Key Words

Atrial fibrillation - transthoracic electrical cardioversion  
efficacy, optimal cardioversion energy, adverse events, risk stratification of stroke, anticoagulation therapy, OA

 

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-1998 by CARDIOnet. All rights reserved.